Olympus aims high with five-year plan
This article was originally published in Clinica
Japanese company Olympus Optical plans to steadily increase the profitability of its medical unit, with operating income targets of ¥7bn ($471m) for this year, Yen67bn for 2005 and Yen89bn for 2007. Its five-year strategy for medical business is two-pronged: to become a total system supplier from basic medicine to clinical medicine and to expand existing businesses. The company has set ambitious sales targets of Yen255bn for this year, Yen315bn for 2005 and Yen400bn for 2007.
You may also be interested in...
Perrigo, Pfizer want the US FDA to postpone its March 1 deadline for conducting nitrosamine risk assessments. Generics exec cites“serious compliance challenges” in conducting these assessments due to difficulty in finding the right lab equipment necessary to quantify nitrosamine daily intake limits.
Deal snapshot: For $425m up front, the pharma obtains a Phase III recombination fusion protein that shows ability to improve hospitalized patients’ clinical status and reduce risk of death.
Previous businesses FDA warned about COVID-19 claims for chlorine dioxide, a bleach solution, were marketing dietary supplements unlawfully. But Pro Breath MD's oral rinses available under the Dentist Select and OraCare brands are allowed and FDA isn’t asking the firm to discontinue distribution.